New Study of Ketamine for Depression Disorders Gets FDA Approval, But Not Medical Marijuana

This is why the recent approval given by the FDA for a study on the use of ketamine infusion for depressive disorder has caught the eyes of many. It comes after a series of advocates have reportedly called for an increase in the available clinical data on the efficacy of ketamine for such conditions.